Yuan Yuan

16PUBLICATIONS
121CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 24, 2026
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.

|Dec 30, 2025
Immune Checkpoint Inhibitor Therapy in Hormone Receptor-Positive Breast Cancer.

David Lin, Jin Sun Lee Bitar, Isabella Ma

|Nov 26, 2025
Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors.

Benjamin T Cooper, Wade T Iams, David B Page

|Oct 29, 2025
Translating Metabolic Interventions into Breast Cancer Therapy: A Comprehensive Review.

Luxi Chen, Stephen L Shiao, Yuan Yuan

|May 07, 2025
Immunotherapy in Breast Cancer: Beyond Immune Checkpoint Inhibitors.

Yeonjoo Choi, Jiayi Tan, David Lin

|Jun 19, 2023
Thrombopoietin Receptor Agonists for Thrombocytopenia Secondary to HER2-Targeted Antibody Drug Conjugates.

Michael Rainone, Saro Kasparian, Tina Nguyen

Pageof 3

Frequent Collaborators

4 joint publications

Susan E Yost

2 joint publications

Jin Sun Lee Bitar

1 joint publications

Karen L Reckamp

1 joint publications

Jasmine A McQuerry